Offsetting The Pain: Forest Pushes Savella To Dampen A Lexapro Sales Slide
This article was originally published in The Pink Sheet Daily
Executive Summary
Forest's Savella is gaining 1,200 to 1,300 new prescribers per week and now has a 3.5 percent share of the market for fibromyalgia treatments